GlassScriptPhysician profile
Matthew J Landherr
NPI 1033554498
$413.48
in general payments reported to CMS, 2019-2025
8 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.33 · 2021: $34.95 · 2022: $30.00 · 2023: $30.27 · 2024: $62.26 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206 · Education: $45.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.66 |
| Education | $45.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $110.49 | 2021-2024 | |
| Allergan, INC. | $97.33 | 2019 | |
| Ucb, INC. | $81.32 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $47.33 | 2025 | |
| Galderma Laboratories, L.P. | $33.98 | 2024-2025 | Nemluvio |
| Biofrontera INC. | $19.95 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $14.48 | 2025 | Dupixent |
| Organon LLC | $8.60 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Landherr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.